Skip to main content
Journal ArticleOPEN ACCESS

Decitabine Induced Delayed Cardiomyopathy in Hematologic Malignancy

  • Agasthi P
  • Narayanasamy H
  • Sorajja D
  • et al.
Case Reports in Cardiology (2018) 2018 1-4
DOI: 10.1155/2018/3953579
N/ACitations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Decitabine is a pyrimidine analogue of nucleoside cytidine, used for the treatment of myelodysplastic syndromes, chronic myelogenous leukemia, and acute myelogenous leukemia. We present a case of cardiomyopathy associated with decitabine used for secondary acute myelogenous leukemia. The patient presented with new heart failure symptoms and an ejection fraction decline.

Cite

CITATION STYLE

APA

Agasthi, P., Narayanasamy, H., Sorajja, D., Slack, J., & Mookadam, F. (2018). Decitabine Induced Delayed Cardiomyopathy in Hematologic Malignancy. Case Reports in Cardiology, 2018, 1–4. https://doi.org/10.1155/2018/3953579

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free